Biosensors for efficient diagnosis of Leishmaniasis: innovations in bioanalytics for a neglected disease by Perinotto, Angelo Cesar et al.
  Universidade de São Paulo
 
2010-12
 
Biosensors for efficient diagnosis of
Leishmaniasis: innovations in bioanalytics for
a neglected disease
 
 
Analytical Chemistry,Washington, DC : American Chemical Society - ACS,v. 82, n. 23, p. 9763-9768,
Dec. 2010
http://www.producao.usp.br/handle/BDPI/49712
 
Downloaded from: Biblioteca Digital da Produção Intelectual - BDPI, Universidade de São Paulo
Biblioteca Digital da Produção Intelectual - BDPI
Departamento de Física e Ciências Materiais - IFSC/FCM Artigos e Materiais de Revistas Científicas - IFSC/FCI
Biosensors for Efficient Diagnosis of
Leishmaniasis: Innovations in Bioanalytics for a
Neglected Disease
Aˆngelo C. Perinoto,† Rafael M. Maki,‡ Marcelle C. Colhone,§ Fabiana R. Santos,§
Vanessa Migliaccio,§ Katia R. Daghastanli,| Rodrigo G. Stabeli,⊥ Pietro Ciancaglini,§
Fernando V. Paulovich,‡ Maria C. F. de Oliveira,‡ Osvaldo N. Oliveira, Jr.,† and
Valtencir Zucolotto*,†
Instituto de Fı´sica de Sa˜o Carlos, USP, CP 369, 13560-970 Sa˜o Carlos, SP, Brazil, Instituto de Cieˆncias Matema´ticas
e de Computac¸a˜o, USP, CP 668, 13560-970 Sa˜o Carlos, SP, Brazil, Faculdade de Filosofia, Cieˆncias e Letras de
Ribeira˜o Preto, USP, Ribeira˜o Preto, SP, Brazil, Departamento de Biofísica da Escola Paulista de Medicina,
UNIFESP, Sa˜o Paulo, SP, Brazil, and Universidade Federal de Rondoˆnia (UNIR) and Fundac¸a˜o Oswaldo Cruz -
Fiocruz Noroeste, Rondoˆnia, Brazil
The need for reliable, fast diagnostics is closely linked to
the need for safe, effective treatment of the so-called
“neglected” diseases. The list of diseases with no field-
adapted diagnostic tools includes leishmaniasis, shigella,
typhoid, and bacterial meningitis. Leishmaniasis, in par-
ticular, is a parasitic disease caused by Leishmania spp.
transmitted by infected phlebotomine sandfly, which
remains a public health concern in developing countries
with ca. 12 million people infected and 350 million at risk
of infection. Despite several attempts, methods for diag-
nosis are still noneffective, especially with regard to
specificity due to false positives with Chagas’ disease
caused by Trypanosoma cruzi. Accepted golden standards
for detecting leishmaniasis involve isolation of parasites
either microscopically, or by culture, and in both methods
specimens are obtained by invasive means. Here, we show
that efficient distinction between cutaneous leishmaniasis
and Chagas’ disease can be obtained with a low-cost
biosensor system made with nanostructured films con-
taining specific Leishmania amazonensis and T. cruzi
antigens and employing impedance spectroscopy as the
detection method. This unprecedented selectivity was
afforded by antigen-antibody molecular recognition pro-
cesses inherent in the detection with the immobilized
antigens, and by statistically correlating the electrical
impedance data, which allowed distinction between real
samples that tested positive for Chagas’ disease and
leishmaniasis. Distinction could be made of blood serum
samples containing 10-5 mg/mL of the antibody solu-
tion in a few minutes. The methods used here are
generic and can be extended to any type of biosensor,
which is important for an effective diagnosis of many
other diseases.
Leishmaniasis is a parasitic neglected disease that remains as
a major public health concern, especially for its high incidence in
developing countries. It affects around 12 million people, and 350
million are at risk of infection.1 The disease is caused by
Leishmania spp., transmitted by infected phlebotomine sandfly.
Depending on the type of parasite causing the infection, leish-
maniasis may be classified as visceral leishmaniasis (VL), diffuse
cutaneous leishmaniasis, mucocutaneous leishmaniasis, and cu-
taneous leishmaniasis (CL).2,3 Many research groups have focused
on novel strategies for treatment and for low-cost, effective
diagnosis systems.4,5 Despite such efforts, diagnosis methods are
still noneffective, with limitations regarding cost, sensitivity,
difficulty in using under field conditions, and specificity.6 The latter
limitation, in particular, applies to cases of cross-reaction with
Chagas’ disease,7,8 and to a lesser extent to tuberculosis and
leprosy.5 Cutaneous leishmaniasis (CL) is frequently diagnosed
by classic clinical investigation, or via laboratorial diagnosis under
microscopic examination of smears or biopsies of skin lesions.9,10
Culturing of replicative Leishmania specimens from the skin lesion
border may also be performed.4,10,11 These methods, however,
often lead to misdiagnosis; the culture assays are positive in only
ca. 70% when the patient has a severe disease.11 Moreover,
contaminations may affect culture procedures, whereas the his-
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topathological examination is often difficult due to dehydration
and deformation of amastigotes.2,4 All of these procedures are
expensive and time-consuming, causing delay in the diagnosis and
hindering precocious treatment of the patient.
The low sensitivity and time-consuming limitations exhibited
by cell culture and microscopic examination of skin lesions may
be overcome by using immunodetection assays, in which antigens
are applied for direct detection of specific antileishmania antibod-
ies. Diagnosis of visceral leishmaniasis has been performed in
immunoblotting assays with Leishmania antigens.12 However,
such methods are limited in the case of cutaneous leishmaniasis,
for anti-Leishmania antibodies are present in the serum at very
low levels.5 Molecular analyses have also been applied to detect
DNA and RNA from leishmania parasites, with PCR methods
being by far the most used.13,14 Despite the high sensitivity and
specificity of the PCR methodology, through which specific
sequences of the parasites can be determined, the method is not
cost-effective, being unsuitable for field diagnosis.
The limitations found in immunoassays and molecular diag-
nosis have motivated the development of integrated electronic
biosensors systems, which in most cases employ nanostructured
biomaterials. These systems are capable of detecting analytes via
specific recognition based upon interaction between protein and
ligands or antigens and antibodies.15,16 Integrated biosensors may
exhibit high sensitivity and specificity, as exemplified with the
detection of pasteurelosis.16 Detection is performed via electrical
measurements, following the concept of a taste sensor, in which
the bioreceptor material is immobilized on the gaps of an
interdigitated electrode and immersed in aqueous solutions
containing different concentrations of the analyte.16 Differences
in the electrical capacitance of the electrodes are correlated to
the type and concentration of the analytes using equivalent electric
circuits. These circuits represent the experimental system, that
is, metallic tracks covered with a layer of biological bioreceptors,
immersed in an electrolyte.17 The latter biodetection systems are
user-friendly and are capable of providing in-field diagnosis within
a short period of time. These technical characteristics are
advantageous for the high throughput inherent in new drug and
diagnosis tests.
In this Article, we present a nanostructured biosensor system
to detect specific anti-leishmania antibodies using capacitance
measurements as the detection method. The system is comprised
of phospholipid liposomes18 incorporating membrane antigenic
proteins as the immobilized phase, which had been anchored to
the surface of interdigitated electrodes. The electrodes containing
antigenic proteins were used to detect antibodies, in which the
biological reaction was converted into variations in the electrical
response (capacitance). Here, we selected a pool of membrane
antigenic proteins from L. amazonensis because of the high
incidence of this species in the north region of Brazil. However,
the system described here may be applied to any other Leishmania
species.
The proteoliposomes incorporating the antigenic proteins were
prepared according to a well-established methodology,18 which
is described in the Experimental Section. The freshly prepared
proteoliposomes were immobilized on interdigitated electrodes
using the layer-by-layer technique,19,20 in conjunction with polya-
midoamine dendrimers generation 4 (PAMAM). Because of their
branched, porous structure, dendrimers have been used for
immobilizing proteins in biosensors, with enhanced sensitivity and
short response times due to diffusion of analytes through the
multilayer structure.21 Furthermore, the porous architecture of
the film is crucial for confining electrical charges within its
structure (e.g., charges generated in the biological reaction),
which are responsible for the detectable changes in the electrical
response.21
EXPERIMENTAL SECTION
Materials. All solutions were prepared using Millipore (Bed-
ford, MA) DirectQ ultrapure water. Tris(hydroxymethyl)amino-
methane (TRIS), bovine serum albumine (BSA), Schneider’s insect
medium, ethylenediaminetetraacetic (EDTA), phenylmethylsul-
fonyl fluoride (PMSF), trans-epoxysuccinyl-L-leucinamido-(4-guani-
dino)btutane (E-64), 1,10-phenanthroline dipalmitoylphosphati-
dylcholine(DPPC),dipalmitoylphosphatidylserine(DPPS),cholesterol,
and sodium dodecyl sulfate (SDS) were purchased from Sigma
(St. Louis, MO); calbiosorb resin was from Calbiochem (San
Diego, CA). Polyamidoamine generation 4 dendrimer (PAMAM)
and poly(allylamine hydrochloride) (PAH) (used as polycations)
and poly(vinyl) sulfonic acid (PVS) (polyanion) were purchased
from Aldrich and used without further purification. Gold (Au)
interdigitated electrodes were lithographically fabricated at the
National Synchroton Laboratory facilities, Campinas, Brazil. Au
tracks (10 µm wide × 70 nm thick) were deposited onto BK7 glass
substrates with a separation distance of 10 µm among the tracks.
Parasites. The parasite strain IFLA/BR/67/PH8 of Leishma-
nia amazonensis was maintained in BALB/c mice (Nunes et al.,
1997; Noronha et al., 1998; Santos et al., 2006).
Serum Preparation of L. amazonensis and T. cruzi. Blood
samples were collected from the BALB/c mice naı¨ve, mice
infected subcutaneously in the hind footpad with 106 stationary
growth phase L. amazonensis promastigotes, and mice infected
intraperitoneally with a nonlethal dose of 300 blood-form
trypomastigotes of the Y strain of T. cruzi. The serum against
total L. amazonensis and T. cruzi antigenic determinants was
obtained from coagulated blood by centrifugation and frozen
at -20 °C until use. The total IgG of positive and negative
serum samples was purified with the Protein G Sepharose 4
Fast Flow (GE Healthcare).
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Solubilization of L. amazonensis Membrane Proteins and
Proteoliposomes Preparation. The procedures to obtain the
crude extract and dissolve the membrane protein of L. amazon-
ensis were performed as described in Santos et al.18 Briefly, the
frozen pellets of amastigotes were resuspended in 5 mM TRIS-
HCl buffer, pH 7.5, containing a protease inhibitor cocktail (1 mM
EDTA, 1.6 mM PMSF, 0.1 mM E-64, and 1 mM 1,10-phenanthro-
line). The suspension was sonicated at 4 °C with three 30 s blasts
at 60 W. SDS was added to a sample with 0.5 mg/mL in protein
of this crude extract of the parasite to reach 0.1% (w/v) at 4 °C.
The solubilization of the crude extract was carried out instanta-
neously, followed by separation with ultracentrifugation at 100 000g
for 1 h. The solubilized protein concentration was estimated in
the supernatant, in the presence of SDS 2.0% (w/v), using
crystallized BSA as standard. Proteoliposomes were prepared by
the cosolubilization method, using a DPPC:DPPS:cholesterol ratio
of 5:1:4 (w/w) as described elsewere.22
Electrode Preparation. PAMAM and proteoliposomes were
used at 1 and 0.7 mg/mL, respectively, in a 5 mM Tris-HCl pH
7.5 buffer solution. Nanostructured LbL films containing up to 12
PAMAM/proteoliposome bilayers were assembled on quartz
slides for UV-vis measurements, and 5-bilayer PAMAM/proteo-
liposome films were deposited onto gold interdigitated electrodes
for capacitance measurements. All substrates were previously
cleaned in a NH4OH/H2O2/H2O (5:1:1 v/v) bath for 20 min.
Deposition of the multilayers was carried out by immersing
the quartz slides or interdigitated electrodes alternately into
the PAMAM (polycationic) and proteoliposomes (polyanionic)
solutions for 5 and 15 min, respectively. After deposition of each
layer, the substrate/film system was immersed for 1 min in
the buffer solution. The deposition process was monitored at
each deposited layer using a quartz crystal microbalance
(QCM).
Electrical Detection of Antiserum. Capacitance measure-
ments were performed with a Solartron impedance/gain phase
analyzer (model 1260A). Unlike the electrochemical experiments,
the in-plane capacitance of the film deposited between the tracks
Figure 1. Amount of PAMAM and proteoliposome adsorbed at each
deposition step. Inset: Frequency change and adsorbed mass for
PAMAM first layer as a function of deposition time, as measured with
a QCM.
Figure 2. Capacitance versus frequency curves for three electrodes immersed into 10-5 mg/mL antibody solutions, as indicated in the legend.
The electrodes comprised a bare electrode (upper left), an electrode containing 5 bilayers of PAMAM/PVS (upper right), and the electrode
containing 5 bilayers of PAMAM/proteoliposome (lower right).
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of the interdigitated electrode was collected in a frequency range
from 10 Hz to 1 MHz, with no need of a reference electrode. All
measurements were taken with the films deposited onto gold
interdigitated electrodes immersed in buffer, and in positive IgG
antibody solutions at different concentrations from 10-2 to 10-10
mg/mL. The negative IgG solutions were comprised of purified
IgGs anti-T. cruzi and were employed at the same concentration
range. Capacitance curves were taken three times for each
sensor, after soaking for 20 min in the analytical solutions. After
each measurement, the sensors were rinsed in the buffer
solution. For comparison, the same sets of experiments were
carried out using bare interdigitated electrodes and interdigi-
tated electrodes coated with a 5-bilayer PAMAM/PVS film (in
the absence of proteoliposomes).
RESULTS AND DISCUSSION
The immobilization process occurred via the alternate immer-
sion of interdigitated electrodes into the PAMAM or proteolipo-
some buffer solutions, with adsorption taking place spontaneously
within 5 min for PAMAM and ca. 15 min for the proteoliposomes.
The adsorption process is depicted in Figure 1, in which the
alternate adsorption of PAMAM (cationic) and the proteoliposome
(anionic) layers was followed by QCM. Adsorption is quite
efficient, with deposition of ca. 500 ng of proteoliposome in each
deposition step, while for the PAMAM layer the deposited mass
was ca. 200 ng. The electrodes containing the PAMAM/proteo-
liposome LbL film were used to detect and distinguish between
L. amazonensis and T. cruzi purified antibodies (purified IgGs)
via impedance measurements. The electrodes were immersed in
different antibodies solutions at several concentrations, and the
changes in the capacitance of the electrodes, under an applied
AC signal, were recorded as a function of frequency, as reported
for capacitance biosensors.15,16 Purified anti-L. amazonensis, T.
cruzi, and negative (mouse serum in the absence of antibodies
against parasites) antibodies solutions were employed at concen-
trations ranging from 10-1 to 10-10 mg/mL. For comparison,
measurements were also taken in a buffer solution, containing
no antibodies, as the control, in a mixture of anti-L. amazonensis
and anti-T. cruzi, and negative antibody solutions.
As a proof-of-concept, the ability of the electrode bearing the
proteoliposomes to distinguish among different antibodies is
shown in Figure 2, which also brings the response of a bare
electrode and of an electrode containing PAMAM adsorbed in
conjunction with poly(vinyl sulfonic acid) (PVS). The latter
electrode was used to verify the ability of an electrode containing
an organic film (where no specific interactions are expected) to
detect the specific antibodies. There is little change in capacitance
for the bare electrode and the PAMAM/PVS electrode upon
immersing into the solutions with 10-5 mg/mL antibodies. In
contrast, the capacitance curve changed significantly for the
PAMAM/proteoliposome electrode, especially in the frequency
region from 102 to 105 Hz. Of special interest is the frequency
region between 1 and 10 kHz, for which the selectivity of the
PAMAM/proteoliposome electrode was highest. The capaci-
tance for the mixture of antibodies was practically the same
as that for the positive anti-L. amazonensis IgGs (at 10 kHz),
which reveals that specific interactions occur upon immersion
of the electrode in the mixture of IgGs, with only the positive
anti-L. amazonensis antibodies binding to the electrode. This
selectivity also applies to the negative antibodies, for the
capacitance of the electrode immersed in the buffer solution
was the same as that of the electrodes immersed in the solution
with negative antibodies (at 10 kHz). Furthermore, with the
PAMAM/proteoliposome electrode, it is also possible to
distinguish the capacitance signal of the anti-T. cruzi IgGs
solution, which is separated from the other systems. The latter
proves that the electrode is quite selective for anti-L. amazon-
ensis IgGs, and no-cross reaction with T. cruzi occurs at this
frequency region.
The dependence between the capacitance and the concen-
tration of positive IgGs has been investigated to yield the
analytical curve of Figure 3. The data clearly point to an almost
linear increase in capacitance as a function of the IgGs
concentration until a plateau is reached at ca. 1 × 10-5 mg/
mL. At this concentration, all the sites in the immobilized
layers available for binding the IgGs had probably been
taken. From a physical point of view, the increase in
Figure 3. Analytical curve showing the dependence of the capaci-
tance on the amount of specific anti-L. amazonensis IgG in the
solution. The electrode contained 5 PAMAM/proteoliposomes bilayers.
Figure 4. PCA plot obtained upon using capacitance data from the
three electrodes at a frequency of 100 Hz. The capacitance values
were collected with the electrodes immersed in the solutions contain-
ing buffer (Tris 5 mM) (b) and different antibodies at 10-5 mg/mL:
negative (O), anti-T. cruzi (×), and positive anti-L. amazonensis (+).
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capacitance may be related to changes in the dielectric
constant of the material, in this case, the PAMAM/proteo-
liposome film, deposited on the gaps of gold tracks in the
interdigitated electrode. The increase in capacitance is
probably related to the generation of additional interfaces
in the dielectric region due to adsorption of antibodies.
To improve the distinguishing ability of the biosensing system,
we combined the capacitance values at 1 kHz obtained with the
three electrodes, (i) bare electrode, (ii) electrode containing 5
PAMAM/PVS bilayers, and (iii) electrode containing 5 PAMAM/
proteoliposome bilayers, and analyzed using principal component
analysis (PCA). The PCA plot in Figure 4 demonstrates that all
analytes can be distinguished for a concentration of 10-5 mg/
mL of IgGs.
To reduce costs for sample preparation and IgGs purification,
as required for in field diagnosis, we investigated the ability of
the electrodes to detect specific antibodies in total serum samples
from mice infected with L. amazonensis, and also from mice
infected with T. cruzi (see details in the Experimental Section).
The total serum had been diluted in buffer at concentrations from
10-2 to 10-10 mg/mL. Note that the positive serum concentra-
tion at 10-10 mg/mL implies a much lower aliquot for positive
anti-L. amzonensis IgGs. Surprisingly, the electrodes could still
distinguish between the two total serum samples, as depicted
in the PCA plot of Figure 5. The data from negative samples
were located in the left part of the plot, whereas data from positive
samples were located in the right side of the chart. The latter
indicated the capacity of the methods to detect positive anti-L.
amazonensis in the total serum, as well as the ability to distinguish
the data from anti-T. cruzi IgGs. Therefore, no cross-reactions
could be noted, and the performance of the diagnosis system is
optimized.
Figure 5. PCA plot built with capacitance data from the three electrodes immersed in total serum samples from mice infected with L. amazonensis
(positive total serum) and from mice infected with T. cruzi (negative total serum). The total serum in both cases was diluted from 10-2 to 10-10
mg/mL.
Figure 6. Sammon’s mapping projection for all samples, with the
standardization procedure applied to the m-dimensional data samples.
In this case, analyses were performed using data from four sensors,
including a sensor based on immobilized proteoliposomes containing
T. cruzi antigens.
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We also stress that use can be made of multidimensional
projection techniques as described elsewhere23 to visualize the
impedance data for all the samples tested in the same plot. Figure
6 shows that a complete separation is reached for the various
samples when the Sammon’s mapping method is employed.
Further details of the application of projection techniques to this
biosensing data can be found in ref 24.
CONCLUSIONS
The need for cost-effective, reliable diagnosis methods, through
which leishmaniasis can be identified and treated in the very early
stages, is evidenced by the fact that first and second-line drugs
used for treating it present high toxicity, several side effects, and
require long-term management. In this Article, we showed a
promising way for rapid, accurate diagnosis of Leishmania infec-
tions using interdigitated electrodes containing immobilized pro-
teoliposomes. Electrical capacitance measurements allowed the
detection of specific anti-L. amazonensis antibodies at concentra-
tions down to 10-5 mg/mL. The use of PCA to statistically
correlate the capacitance data permitted the distinction between
positive and negative total serum samples. The methods used
here are generic and may be extended to the diagnosis of
bacterial, protozoan, and helminth infectious diseases affecting
developing countries, including tuberculosis, malaria, and other
neglected diseases, such as the African sleeping sickness,
onchocerciasis, lymphatic filariasis, and schistosomiasis.
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